Clinical Trials Directory

Trials / Completed

CompletedNCT02892786

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Institut de Cancérologie de Lorraine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The dissemination of individual tumor cells is a common phenomenon in solid cancers. Detection of tumor cells in peripheral blood circulating tumor cells (CTC) in nonmetastatic situation is of high prognostic significance. The objective of our study was to detect circulating tumor cells in two different method in patient with head and neck squamous cell carcinoma .

Conditions

Interventions

TypeNameDescription
OTHERCirculating Tumor CellsPatients with stage III and IV head and neck squamous cell carcinoma undergoing surgery were enrolled in this study 5 and 7.5 ml of peripheral venous blood will be taken before the surgery, just at the end of surgery and one week after surgery Analysis was performed by RT-PCR and the CellSearch™ method using immunomagnetic and fluorescence approaches. Patients will be followed every 3 months for two years.

Timeline

Start date
2010-12-08
Primary completion
2017-12-01
Completion
2018-04-01
First posted
2016-09-08
Last updated
2018-08-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02892786. Inclusion in this directory is not an endorsement.

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (NCT02892786) · Clinical Trials Directory